ABSTRACT: Glucagon-like peptide-1 (GLP-1) agonists are a class of medications indicated for type 2 diabetes and obesity that may play a role in the management of cutaneous disease, in part due to their anti-inflammatory effects
The American Diabetes Association and USDA Dietary Guidelines recommend focusing on nutrient-dense, high-fiber foods including vegetables, lean proteins, and whole grains to maximize weight loss while on GLP-1 therapy
The brain is highly susceptible to oxidative stress because it consumes a large amount of oxygen and has a high fat content
The drug received approval from both the US FDA and the European Union in 2022 for the treatment of type 2 diabetes, demonstrating signicant glucose-lowering and weight-loss efects in multiple clinical trials
Acute cases of joint pain may be triggered by certain conditions, like medications, smoking or an imbalanced diet, whereas chronic joint pain generally occurs alongside pre-existing medical conditions